|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 24, 2017 ) As the second largest internal organ, liver performs many complex functions in the body (bile secretion, toxin removal, and fighting infections, etc.). Malfunctioning of liver can be life-threatening as it can cause multiple acute and chronic diseases (hepatitis, non-alcoholic fatty liver disease, liver cancer, liver tumour, and liver cirrhosis, among others). The initial symptoms of liver damage include nausea, fatigue, diarrhoea, jaundice, swollen abdomen, and mental disorientation among other. Chronic liver diseases are considered to be one of leading cause of death in Latin America.
View Full Report @ http://www.marketdataforecast.com/market-reports/latin-america-liver-disease-treatment-market-1737/
The growth of Liver Disease Treatment market is majorly driven by factors such as rising public awareness, growth in geriatric population, and unmet needs for the treatment of liver cancer. Alcohol induced liver diseases are highly prevalent in the region, thereby spiking the demand for the product. Furthermore, rise in obese population, specially Mexico where 32.8% of population suffers from obesity, has increased the risk of Non-Alcoholic Fatty Liver Disease in the region, hence fueling the demand for the product. The key restraints of the market are complex drug approval procedure, side-effects of the product (fatigue, fever, and depression), and expensive treatment.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/latin-america-liver-disease-treatment-market-1737/request-sample
Latin America Liver Disease Treatment Market is segmented on the basis of Treatment Modality and Disease Type. Based on Treatment Modality, the market is classified into Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids, and Others. On the basis of Disease Type, the market is classified into Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol Induced, Liver Cancer, and Others
The Latin America market is geographically segmented into Brazil, Argentina, Mexico, and rest of Latin America.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/latin-america-liver-disease-treatment-market-1737/inquire
The major companies dominating the Latin American Liver Disease Treatment Market are Gilead Science Inc. (U.S.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Johnson & Johnson (U.S.), Novartis (Switzerland), Roche (Switzerland), Sanofi-Aventis (France), Abbott Laboratories (U.S.), Bayer Schering AG (Germany), and AstraZeneca (United Kingdom).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
